Citation

Hersh RG. Focus (Am. Psychiatr. Publ.) 2022; 20(4): 353-357.

Copyright

(Copyright © 2022, American Psychiatric Publishing)

DOI

10.1176/appi.focus.20220054

PMID

37200872

PMCID

PMC10187396

Abstract

Standard psychiatric risk management challenges are routinely amplified in the treatment of patients with primary or co-occurring borderline personality disorder diagnosis. Most psychiatrists receive limited guidance during training or as part of continuing medical education about specific risk management concerns in work with this patient population; nevertheless, these concerns can occupy a disproportionate amount of time and energy in clinical practice. The goal of this article is to review the frequently observed risk management quandaries encountered in work with this patient population. The more familiar risk management dilemmas related to management of suicidality, potential boundary violations, and patient abandonment, are considered. In addition, salient contemporary trends in prescribing, hospitalization, training, diagnostic classification, models of psychotherapeutic treatment, and use of emerging technologies in provision of care, are explored in terms of their impact on risk management.

Language: en

Keywords

borderline personality disorder; boundary violations; pharmacotherapy; risk management; suicide